Does Esperion Therapeutics Inc (ESPR) Have What it Takes to be in Your Portfolio Thursday?

A rating of 97 puts Esperion Therapeutics Inc (ESPR) near the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. Esperion Therapeutics Inc's score of 97 means it scores higher than 97% of stocks in the industry. Esperion Therapeutics Inc also received an overall rating of 80, putting it above 80% of all stocks. Drug Manufacturers - Specialty & Generic is ranked 91 out of the 148 industries.

ESPR has an Overall Score of 80. Find out what this means to you and get the rest of the rankings on ESPR!

See Full ESPR Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 80 means the stock is more attractive than 80 percent of stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Esperion Therapeutics Inc Stock Today?

Esperion Therapeutics Inc (ESPR) stock is flat 0% while the S&P 500 has gained 0.06% as of 1:43 PM on Thursday, Mar 28. ESPR is flat $0.00 from the previous closing price of $2.62 on volume of 3,775,119 shares. Over the past year the S&P 500 has gained 30.39% while ESPR has gained 47.19%. ESPR lost -$2.03 per share the over the last 12 months. Click Here to get the full Stock Report for Esperion Therapeutics Inc stock.